Abstract
BackgroundIntra-tumoral heterogeneity (ITH) can limit effective anti-tumor immune responses despite the presence of immunogenic neoantigens. Yet, there is little mechanistic insight into how ITH blunts anti-tumor T cell responses or...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
